Yuwei Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuwei Zhang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Bo Pang
Infectious Disease Prevention and Control Section, Shandong Center for Disease Control and Prevention, Jinan, Shandong Province, People’s Republic of China
2 shared publications- Xiaolin Jiang
School of Public Health and Health Management, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong Province, People's Republic of China; School of Public Health, Shandong Second Medical University, Weifang, Shandong Province, People's Republic of China; Shandong Center for Disease Control and Prevention, Jinan, Shandong Province, People's Republic of China
2 shared publications Caiyun Chang
Institute for Infectious Disease Control, Jinan Center for Disease Control and Prevention, Jinan, Shandong Province, People’s Republic of China
1 shared publicationJianxing Wang
Infectious Disease Prevention and Control Section, Shandong Center for Disease Control and Prevention, Jinan, Shandong Province, China
1 shared publicationJinzhong Zhang
Liaocheng Center for Disease Control and Prevention, Liaocheng, Shandong Province, China
1 shared publicationLianxiang Zhao
School of Public Health and Management, Binzhou Medical University, Yantai, Shandong Province, China
1 shared publication
Latest Publications
- Open Access
- 1 November 2024
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 8357-8374
Transcriptome Profiles Characteristics of the Peripheral Immune in Patients with Severe Fever with Thrombocytopenia Syndrome
Purpose: Severe fever with thrombocytopenia syndrome (SFTS) is an acute viral infection disease with a high mortality, but there are no specific effective drugs or vaccines available for use. To develop effective treatment methods, more basic researches are urgently needed to elucidate the response mechanisms of patients. Patients and Methods: Here, we conducted the transcriptomic analysis of peripheral immunity in 14 SFTS patients, ranging from moderate infection to severe and fatal disease. Results: The results showed orderly cytokine signaling pathway modulation in moderate patients, cellular immunosuppression in severe patients, and significant dysregulation of the inflammatory response and coagulation dysfunction characteristic of deceased patients. In addition, WGCNA further showed a significant positive correlation between fatal outcomes and B cell and immunoglobulin mediated immune function modules, as well as a significant negative correlation with coagulation function modules. Conclusion: Overall, our research findings systematically observed potential immune mechanisms underlying clinical symptom heterogeneity and noteworthily revealed multiple signaling pathways leading to coagulation dysfunction in fatal outcomes, not just related to decreased platelet count, which can further elucidate the interaction between viruses and hosts and contribute to clinical treatment.
- 1 November 2024
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 8357-8374
Open AccessTranscriptome Profiles Characteristics of the Peripheral Immune in Patients with Severe Fever with Thrombocytopenia Syndrome
Purpose: Severe fever with thrombocytopenia syndrome (SFTS) is an acute viral infection disease with a high mortality, but there are no specific effective drugs or vaccines available for use. To develop effective treatment methods, more basic researches are urgently needed to elucidate the response mechanisms of patients. Patients and Methods: Here, we conducted the transcriptomic analysis of peripheral immunity in 14 SFTS patients, ranging from moderate infection to severe and fatal disease. Results: The results showed orderly cytokine signaling pathway modulation in moderate patients, cellular immunosuppression in severe patients, and significant dysregulation of the inflammatory response and coagulation dysfunction characteristic of deceased patients. In addition, WGCNA further showed a significant positive correlation between fatal outcomes and B cell and immunoglobulin mediated immune function modules, as well as a significant negative correlation with coagulation function modules. Conclusion: Overall, our research findings systematically observed potential immune mechanisms underlying clinical symptom heterogeneity and noteworthily revealed multiple signaling pathways leading to coagulation dysfunction in fatal outcomes, not just related to decreased platelet count, which can further elucidate the interaction between viruses and hosts and contribute to clinical treatment.
- Open Access
- 19 December 2022
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 52, 102531
Neutralization of SARS-CoV-2 omicron after BBIBP-CorV and ZF2001 booster vaccination
- 19 December 2022
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 52, 102531
Open AccessNeutralization of SARS-CoV-2 omicron after BBIBP-CorV and ZF2001 booster vaccination